Computerised cognitive behaviour therapy (CBT) for the treatment of anxiety and effects on neuropsychological functioning and hormone levels
Completed
- Conditions
- Anxiety disorders - Panic disorder, social anxiety disorder and generalised anxiety disorder (GAD)Mental Health - Anxiety
- Registration Number
- ACTRN12606000349549
- Lead Sponsor
- niversity of Otago, New Zealand
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Current Diagnostic and Statistical Manual of Mental Disorders (DSM IV ) primary diagnosis of panic disorder, social phobia or generalised anxiety disorderAccess to the internet and sufficient competency with English language.
Exclusion Criteria
DSM IV primary diagnosis of obsessive compulsive disorder, specific phobia or post traumatic stress disorder (PTSD)Current diagnosis of psychotic illness, bipolar 1 disorder, alcohol or drug dependenceDisabling cardiac or respiratory disordersSerious neurological disordersStarted on or changed dose of antidepressant medication in last 6 weeks.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare effectiveness of computerised CBT for the treatment of anxiety disorders with a waiting list control condition[Outcome will be assessed at 3 months(end of treatment) and at 6 months (after 3 months follow up).]
- Secondary Outcome Measures
Name Time Method a) To evaluate the acceptability and satisfaction of computerised CBT for the treatment of anxiety disorders[Outcome will be assessed at 3 months(end of treatment) and at 6 months (after 3 months follow up).];b)To assess recruitment and retention of participants to this clinical trial[Outcome will be assessed at 3 months(end of treatment) and at 6 months (after 3 months follow up).];c) to compare the effects of computerised CBT on neuropsychological functioning and tests of facial emotion recognition compared with waiting list control[Outcome will be assessed at 3 months(end of treatment) and at 6 months (after 3 months follow up).];d)To investigate plasma oxytocin levels in subjects with anxiety disorders before and after treatment.[Outcome will be assessed at 3 months(end of treatment) and at 6 months (after 3 months follow up).]